Position in AGEN
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$73,822
-$10,566 QoQ
Shares Held
24,125
-4.5% QoQ
Ownership
0.054%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#41
of 103 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AGEN Over Time
Shares Held
Position Value (USD)
Derivatives in AGEN
reported options exposure · as of Mar 31, 2025CallValue
$3,020
CallShares
2,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Key Client Fiduciary Advisors, LLC holds $82,963 across 2 Biotechnology names. AGEN ranks #1 (89.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AGEN |
Agenus Inc
This page
|
24,125 | $73,822 | |
| 2 | HUMA |
Humacyte, Inc.
|
11,720 | $9,141 |
All Filings in AGEN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $73,822 | 24,125 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $84,388 | 25,266 | Shares | Sole | 2026-04-09 | |
| 2025-12-31 | $85,872 | 27,348 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $151,047 | 39,233 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $180,670 | 39,534 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $3,020 | 2,000 | Call | Sole | 2025-04-10 | |
| 2025-03-31 | $93,322 | 61,803 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $186,541 | 68,081 | Shares | Sole | 2025-01-17 | |
| 2024-12-31 | $5,480 | 2,000 | Call | Sole | 2025-01-17 | |
| 2024-09-30 | $369,439 | 67,416 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $1,168,379 | 69,754 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $498,202 | 858,969 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $516,649 | 622,469 | Shares | Sole | 2024-01-09 | |
| 2023-09-30 | $604,816 | 535,236 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $866,537 | 541,586 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $808,032 | 531,600 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $115,199 | 48,000 | Call | Sole | 2023-01-17 | |
| 2022-12-31 | $1,176,839 | 490,350 | Shares | Sole | 2023-01-17 | |
| 2022-09-30 | $98,399 | 48,000 | Call | Sole | 2022-10-12 | |
| 2022-09-30 | $1,038,273 | 506,475 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $974,800 | 502,475 | Shares | Sole | 2022-07-19 | |
| 2022-06-30 | $93,119 | 48,000 | Call | Sole | 2022-07-19 | |
| 2022-03-31 | $115,619 | 47,000 | Call | Sole | 2022-04-18 | |
| 2022-03-31 | $1,044,724 | 424,685 | Shares | Sole | 2022-04-18 | |
| 2021-12-31 | $1,102,157 | 342,285 | Shares | Sole | 2022-03-01 | |
| 2021-12-31 | $196,419 | 61,000 | Call | Sole | 2022-03-01 | |
| No filing history on record for this holder in this stock. | ||||||